Compare TACT & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TACT | HYFT |
|---|---|---|
| Founded | 1996 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.6M | 56.5M |
| IPO Year | 1996 | 2017 |
| Metric | TACT | HYFT |
|---|---|---|
| Price | $4.51 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.33 |
| AVG Volume (30 Days) | 24.9K | ★ 242.4K |
| Earning Date | 11-12-2026 | 12-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.23 | $12.86 |
| Revenue Next Year | $4.53 | $22.94 |
| P/E Ratio | $154.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.06 | $0.78 |
| 52 Week High | $6.02 | $3.00 |
| Indicator | TACT | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 20.81 |
| Support Level | $4.32 | N/A |
| Resistance Level | $5.42 | $1.50 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 17.39 | 10.93 |
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.